Royalty Pharma RPRX
NASDAQ RPRX
$58.22 -0.15 (-0.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Net Income towards Common Stockholders (2019 - 2026)

Updated

Royalty Pharma (RPRX) reported Net Income towards Common Stockholders of $17.88 million for Q2 2026, down 44.4% from $32.18 million a year earlier and down 93.9% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Royalty Pharma's Net Income towards Common Stockholders came in at $815 million, down 20.4% year-over-year; for FY2025, it was $770.95 million, down 10.2% from FY2024.

  • Net Income towards Common Stockholders has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
  • By year, Net Income towards Common Stockholders came in at $858.98 million in FY2024 (-24.3%), $1.13 billion in FY2023, $42.83 million in FY2022 (-93.1%) and $619.73 million in FY2021 (-36.4%).
  • The Q2 2026 figure ranks as the lowest quarterly Net Income towards Common Stockholders since Q1 2024.
  • Year over year, Net Income towards Common Stockholders gained in three of the last seven quarters, with growth averaging 66.1%.
  • The high point for year-over-year Net Income towards Common Stockholders in five years was Q3 2024 (growth of 654.3%); the low point was Q1 2024 (a decline of 98.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $294.69 million (Q1 2026), $214.21 million (Q4 2025) and $288.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Orix 43.85 Bn 44.35 Bn - 1.76 Bn
2 Rocket Companies 43.67 Bn 29.35 Bn - 230.00 Mn
3 Royalty Pharma 33.56 Bn 33.48 Bn - 17.88 Mn
4 Federal National Mortgage Association Fannie Mae 25.52 Bn 25.52 Bn - 152.00 Mn
5 Synchrony Financial 23.24 Bn -44.73 Bn - 864.00 Mn
6 Affirm Holdings 22.66 Bn 16.35 Bn - 1.62 Bn
7 Royal Gold 20.35 Bn 19.57 Bn 390.45 Mn 236.39 Mn
8 Annaly Capital Management 15.27 Bn 6.37 Bn - 781.64 Mn
9 Ares Capital 13.74 Bn 11.17 Bn - 171.00 Mn
10 Federal Home Loan Mortgage 12.68 Bn -6.06 Bn - -9.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.88 Mn
Mar 31, 2026 294.69 Mn
Dec 31, 2025 214.21 Mn
Sep 30, 2025 288.22 Mn
Jun 30, 2025 32.18 Mn
Mar 31, 2025 239.35 Mn
Dec 31, 2024 208.21 Mn
Sep 30, 2024 543.99 Mn
Jun 30, 2024 102.00 Mn
Mar 31, 2024 4.78 Mn
Dec 31, 2023 494.34 Mn
Sep 30, 2023 72.11 Mn
Jun 30, 2023 227.63 Mn
Mar 31, 2023 340.76 Mn
Dec 31, 2022 -456.08 Mn
Sep 30, 2022 142.65 Mn
Jun 30, 2022 304.50 Mn
Mar 31, 2022 51.76 Mn
Dec 31, 2021 7.90 Mn
Sep 30, 2021 101.93 Mn
API Access

Royalty Pharma Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RPRX&period=max&api_key=YOUR_API_KEY